United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis a virus inactivated - suspension for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - varicella-zoster virus live attenuated (oka strain) - powder and solvent for solution for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

boc limited - oxygen, quantity: 0.5 l/l; nitrous oxide, quantity: 0.5 l/l - gas, medicinal - excipient ingredients: - indications as at 1 november 2001: "nitrous oxide with oxygen (entonox) is indicated in adults and children for analgesia." this approval is based on the evaluation of the information and data provided with the original letter of application and with any subsequent correspondence and submissions relating to the application.

Australia - English - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - nitrous oxide, quantity: 50 % v/v; oxygen, quantity: 50 % v/v - gas, medicinal - excipient ingredients: - indications as at 7 november 2001: nitrous oxide with oxygen (equanox) is indicated in adults and children for analgesia.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - hepatitis a virus inactivated - suspension for injection

New Zealand - English - Ministry for Primary Industries

orion agriscience limited - brodifacoum - brodifacoum 0.05 g/kg - vertebrate toxic agent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - difenacoum - bait - difenacoum coumarin active 0.05 g/kg - vertebrate poison

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

amgrow pty ltd - difenacoum - bait - difenacoum coumarin active 0.05 g/kg - vertebrate poison

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - naloxone hydrochloride dihydrate, quantity: 400 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; dilute hydrochloric acid - this product accepted for registration as 'currently supplied' at the time of commencement of the act. approval for listing of these goods as pharmaceutical benefits were approved as specified in the letter of 29 october 1992 from dr alex proudfoot. indications: for the complete or partial reversal of narcotic depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone and the narcotic-antagonist analgesics such as nalbuphine, methadone and butorphanol. indications as at 8 january 2004: naloxone is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, codeine, morphine and heroin, and the mixed opioid agonist-antagonist analgesics such as pentazocine. naloxone is also indicated for the diagnosis of suspected acute opioid overdosage.

New Zealand - English - Ministry for Primary Industries

orion agriscience limited - brodifacoum - brodifacoum 0.05 g/kg - vertebrate toxic agent